Analysis of the role of p38 MAP kinase in heart failure using transgenic mice
Analysis of the role of p38 MAP kinase in heart failure using transgenic mice
批准号:
11307012
负责人:
SASAYAMA Shigetake
金额:
$24.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
我们利用心肌炎、心肌肥厚和心肌梗死的小鼠模型,研究了细胞因子在心脏损伤发病机制中的作用。这些数据表明,无论心脏损伤的原因是什么,炎性细胞因子在心力衰竭的发生和发展中发挥着重要作用。应激激活的MAPK是调节细胞因子表达的重要信号级联信号之一。最重要的是,p38MAPK被认为在病毒感染、压力超负荷和氧化应激反应中诱导心肌肥大和细胞凋亡。本项目旨在通过转基因模型阐明p38MAPK级联蛋白在体内的作用。首先,我们尝试在小鼠中过表达pMAPK。然而,它是胚胎致死的。接下来,我们培育了一株MKK6EE转基因小鼠。MKK6EE是一种调节pMAPK的MKK6的结构活性形式,但在转基因品系中仅在mRNA水平检测到MKK6EE。未检测到MKK6EE蛋白和活性。我们进一步试图造成压力超负荷和心肌梗死,但心肌肥厚或心脏损伤的程度没有区别。因此,MKK6-p38信号通路参与了胚胎的早期发育。
英文摘要
We investigated the role of cytokines in the pathogenesis of cardiac injury using murine model of myocarditis, cardiac hypertrophy, and myocardial infarction. These data suggest that inflammatory cytokines play an important role in the development and progression of heart failure regardless of the cause of cardiac injury. Stress-activated MAPKs are one of the important signal cascade which regulate the expression of cytokines. Above all, p38MAPK is suggested to induce cardiac hypertrophy and apoptosis in responses to viral infection, pressure overload, and oxidative stress. This project is designed to clarify the in vivo role of p38MAPK cascade by transgenic model. First we tried to overexpress pMAPK in mouse. However it was embryonic lethal. Next, we developed a line of MKK6EE transgenic mouse. MKK6EE is a constitutively active from of MKK6, a MAPKK which regulates pMAPK.In the transgenic line, however, MKK6EE was detected only at mRNA level. No MKK6EE protein nor activity was detected. We further tried to make pressure-overload and myocardial infarction in that mice, but the extent of cardiac hypertrophy or the cardiac injury was not different. Thus, it was suggested that MKK6-p38 signaling is involved in the early development of embryo.
期刊论文(43)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Matsumori A, et al.: "Pimobendan inhibits the activation of transcription factor NF-κB.A mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase."Life Sci. 67. 2513-2519 (2000)
Matsuori A 等人:“匹莫苯丹抑制转录因子 NF-κB 的激活。这解释了其抑制细胞因子产生和诱导型一氧化氮合酶的机制。”Life Sci. 67. 2513-2519 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishimura H, et al.: "Autoimmune dilated cardiomyopathy in PD-1 receptor deficient mice."Science. 291. 391-322 (2001)
Nishimura H 等人:“PD-1 受体缺陷小鼠的自身免疫性扩张型心肌病。”科学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsumori A.: "The role of inflammatory mediators in the failing heart : Immunomodulation of cytokines in experimental models of heart failure."Heart Failure Reviews. 6. 129-136 (2001)
Matsumori A.:“炎症介质在心脏衰竭中的作用:心力衰竭实验模型中细胞因子的免疫调节。”心力衰竭评论。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Furukawa Y, Matsumori A, Ohashi N, Shioi T, Ono K, Harada A, Matsushima K, Sasayama S.: "Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries."Circ Res.
Furukawa Y、Matsumori A、Ohashi N、Shioi T、Ono K、Harada A、Matsushima K、Sasayama S.:“抗单核细胞趋化蛋白-1/单核细胞趋化和激活因子抗体抑制受损大鼠颈动脉中的新内膜增生。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakamura K, et al.: "Hepatitis C virus infection in a patient with dermatomyositis and left ventricular dysfunction."Jpn Circ J. 64. 623-626 (2000)
Nakamura K 等人:“皮肌炎和左心室功能障碍患者的丙型肝炎病毒感染。”Jpn Circ J. 64. 623-626 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 36 条
Analysis of novel proteins produced by vascular tissues and their clinical application
-
批准号:11557052
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.19万
-
财政年份:1999
-
负责人:SASAYAMA Shigetake
-
依托单位:
Analysis of signal transduction among cells in the pathogenesis of heart failure and its application for the diagnosis and treatment
-
批准号:08407018
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$24.96万
-
财政年份:1996
-
负责人:SASAYAMA Shigetake
-
依托单位:
DEVELOPMENT OF GENE THERAPY FOR CARDIOVASCULAR DISEASES
-
批准号:08044273
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$10.11万
-
财政年份:1996
-
负责人:SASAYAMA Shigetake
-
依托单位:
Cellular interaction in pathogenesis of cardiac dysfuction
-
批准号:07044253
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.31万
-
财政年份:1995
-
负责人:SASAYAMA Shigetake
-
依托单位:
Oxydant Stress in the Cardiomyocyte and Its Roles on the Cellular Signaling
-
批准号:07557343
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$1.15万
-
财政年份:1995
-
负责人:SASAYAMA Shigetake
-
依托单位:
Molecular Pathogenesis of Virus-Induced Myocardial Injury
-
批准号:05044162
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$6.4万
-
财政年份:1993
-
负责人:SASAYAMA Shigetake
-
依托单位:
Studies on the cytokines in heart failure
-
批准号:05404034
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$22.14万
-
财政年份:1993
-
负责人:SASAYAMA Shigetake
-
依托单位:
Experimental Studies on the Occurrence of Cardiac Hypertrophy in Ischemic Heart and Its Possible Mechanisms
-
批准号:63480224
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.16万
-
财政年份:1988
-
负责人:SASAYAMA Shigetake
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KCTD10对2型免疫反应(Th2)的调控研究
-
批准号:2020JJ4441
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:任凯群
-
依托单位:
IL-6受体泛素化调控机制
-
批准号:32070775
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李姝
-
依托单位:
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
-
批准号:31970735
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:江静
-
依托单位:
USP13调控IL-18诱导的NF-κB活化的分子机制研究
-
批准号:31900556
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:林恒
-
依托单位:
let-7通过SOCS1调控巨噬细胞极化及其在前列腺癌进展中的作用
-
批准号:81560465
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2015
-
负责人:王志刚
-
依托单位:
纳米微粒载NF-κB圈套基因对神经发育缺陷大鼠模型的干预研究
-
批准号:30870892
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2008
-
负责人:吕路线
-
依托单位: